Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy.
CONCLUSION: Factoring in all treatment-related costs, the use of niraparib could result in significant cost savings compared with other maintenance treatment options.
PMID: 30935213 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Medicare | Ovarian Cancer | Ovaries